Skip to content

: Effects of inspiratory muscle training on fatigue and dyspnea in patients with chronic heart failure

: Effects of inspiratory muscle training on fatigue and dyspnea in patients with chronic heart failure

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016071324080N2
Enrollment
100
Registered
2016-11-27
Start date
2016-07-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure. Heart failure, unspecified

Interventions

Intervention 1: Treatment group: Treatment group will perform Inspiratory Muscle Training (IMT) for 30min, 7 days per week, for 6weeks using the Threshold device (Respironics).each seven session will
Rehabilitation
Treatment group: Treatment group will perform Inspiratory Muscle Training (IMT) for 30min, 7 days per week, for 6weeks using the Threshold device (Respironics).each seven session will perform at home.
control group: control group will receive usual care

Sponsors

Lorestan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age 18-65 years; being clinically stable; left ventricular ejection fraction (LVEF) below 40%; New York Heart Association (NYHA) Class II and III; no change in medications over three months; Patients with cardiac pacemaker were included after 6 weeks after implementation. Exclusion criteria: having acute myocardial infarction; cognitive disorders; complex arrhythmias; uncontrolled hypertension; angina pectoris; recent viral infections (6 months prior to study); orthopedic problems; and rheumatologic diseases.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Fatigue. Timepoint: immediately before intervention and 6 weeks after intervention. Method of measurement: fatigue severity scale (FSS).

Secondary

MeasureTime frame
Dyspnea. Timepoint: immediately before intervention and 6 weeks after intervention. Method of measurement: Modified Medical Research Council dyspnea scale(MRC).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmir Hossein Hossein Pour

Lorestan University of Medical Sciences

amir.ho3ein19955313@gmail.com+98 66 3312 0140

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026